Boston, MA, United States of America

Tracey Menhall



 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tracey Menhall: Innovator in Iron Homeostasis

Introduction

Tracey Menhall is a notable inventor based in Boston, MA, who has made significant contributions to the field of iron homeostasis. With a total of two patents to his name, Menhall's work focuses on innovative compositions and methods that address critical health issues related to iron regulation.

Latest Patents

Menhall's latest patents include compositions for regulating iron homeostasis and methods of using the same. The first patent describes hemojuvelin-IgG Fc domain fusion proteins, along with their variants, derivatives, fragments, and peptide mimetics. These innovations are aimed at regulating iron homeostasis and treating diseases associated with iron imbalance. The second patent reiterates similar themes, emphasizing the importance of these fusion proteins in the regulation of iron homeostasis and their potential therapeutic applications.

Career Highlights

Throughout his career, Tracey Menhall has worked with prominent organizations, including The General Hospital Corporation and Ferrumax Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Menhall has collaborated with esteemed colleagues such as Herbert Y Lin and Jodie L Babitt. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking solutions in the field of iron homeostasis.

Conclusion

Tracey Menhall's contributions to the field of iron homeostasis through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments related to iron regulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…